RecruitingNCT06694181

Safe and Explainable AI

SAFE AND EXPLAINABLE AI-ENABLED DECISION MAKING FOR PERSONALIZED CLINICAL DECISION SUPPORT


Sponsor

Abramson Cancer Center at Penn Medicine

Enrollment

300,000 participants

Start Date

Nov 29, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

While current AI technology is suitable for automating some repetitive clinical tasks, technical challenges remain in solving critical and gainful problems in the domains of patient and disease management. The proposed research seeks to address issues in medical AI, such as integrating medical knowledge effectively, making AI recommendations explainable to clinicians, and establishing safety guarantees.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Cardiology 18 years of age and older, admitted to any of the Penn Medicine hospitals from 2017 to the present. Sepsis 18 years of age at the time of presentation to an emergency department or admission to any Penn Medicine hospital from July 1, 2017, onward will be eligible as this represents the population at risk for acquiring sepsis Oncology 18 years of age and older with a diagnosis of invasive breast cancer (Stage 1-4) in the Penn Cancer registry

Exclusion Criteria1

  • Cardiology Patients whose primary admission diagnosis was cardiac arrest Sepsis Those with pre-existing limitations on life-sustaining therapy will be excluded because their eligibility for sepsis definitions, care received, and outcomes, may be significantly and variably affected by pre-existing limitations on care. Oncology There are no other exclusions.

Interventions

OTHERAI-PERSONALIZED CLINICAL DECISION SUPPORT

AI-ENABLED DECISION MAKING FOR PERSONALIZED CLINICAL DECISION SUPPORT


Locations(1)

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06694181


Related Trials